These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18654171)

  • 1. How to commercialize nanotechnology.
    Helmus MN
    Nat Nanotechnol; 2006 Dec; 1(3):157-8. PubMed ID: 18654171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 3. Commercialization of nanotechnology.
    Hobson DW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):189-202. PubMed ID: 20049790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will the nanomedicine "patent land grab" thwart commercialization?
    Bawa R
    Nanomedicine; 2005 Dec; 1(4):346-50. PubMed ID: 17292108
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathway to commercialization for nanomedicine.
    Flynn T; Wei C
    Nanomedicine; 2005 Mar; 1(1):47-51. PubMed ID: 17292057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 7. The economy of promises.
    Jones R
    Nat Nanotechnol; 2008 Feb; 3(2):65-6. PubMed ID: 18654457
    [No Abstract]   [Full Text] [Related]  

  • 8. Applying the marketing mix (5 ps) to bionanotechnology.
    Tomczyk MS
    Methods Mol Biol; 2011; 726():393-411. PubMed ID: 21424463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are natural resources a curse?
    Jones R
    Nat Nanotechnol; 2007 Nov; 2(11):665-6. PubMed ID: 18654396
    [No Abstract]   [Full Text] [Related]  

  • 10. Economics of stocker production.
    Peel DS
    Vet Clin North Am Food Anim Pract; 2006 Jul; 22(2):271-96. PubMed ID: 16814017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small world, big hopes.
    Watanabe M
    Nat Mater; 2004 Jan; 3(1):73-4. PubMed ID: 14704788
    [No Abstract]   [Full Text] [Related]  

  • 12. Green groups baulk at joining nanotechnology talks.
    Powell K
    Nature; 2004 Nov; 432(7013):5. PubMed ID: 15525946
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges for a champion.
    Nat Nanotechnol; 2007 Mar; 2(3):129. PubMed ID: 18654233
    [No Abstract]   [Full Text] [Related]  

  • 14. The stocker cattle supply chain.
    Falconer LL; Anderson DP
    Vet Clin North Am Food Anim Pract; 2006 Jul; 22(2):297-303. PubMed ID: 16814018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denmark in focus.
    Med Device Technol; 2004; 15(1):74. PubMed ID: 14994640
    [No Abstract]   [Full Text] [Related]  

  • 16. Unbundling a practice. At hearing, a leading GPO says it plans to stop controversial marketing strategy.
    Becker C
    Mod Healthc; 2003 Jul; 33(29):14-5. PubMed ID: 12929511
    [No Abstract]   [Full Text] [Related]  

  • 17. Transnational models for regulation of nanotechnology.
    Marchant GE; Sylvester DJ
    J Law Med Ethics; 2006; 34(4):714-25. PubMed ID: 17199813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The five competitive forces that shape strategy.
    Porter ME
    Harv Bus Rev; 2008 Jan; 86(1):78-93, 137. PubMed ID: 18271320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marketing groups merge. Rx communications pros get national organization.
    Robeznieks A
    Mod Healthc; 2007 Jun; 37(25):17. PubMed ID: 17824503
    [No Abstract]   [Full Text] [Related]  

  • 20. From innovation to successful commercialization: assessing value and investment--does the equation make sense?
    Toneguzzo F
    Surgery; 2008 Feb; 143(2):165-8. PubMed ID: 18242328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.